1 September 2024

Starpharma Investor Presentation to Goldman Sachs Conference

Melbourne, Australia; 3 April 2019: Starpharma (ASX: SPL, OTCQX: SPHRY) will today present to institutional investors at the Goldman Sachs Tenth Annual Emerging Companies Conference in Sydney.

The invitation-only Goldman Sachs Conference brings together around 40 ASX listed companies over a two-day event with approximately 100 investors ranging from specialist small and mid-cap, to large-cap funds, including a number of offshore investors.

During the conference Starpharma’s Chief Executive Officer, Dr Jackie Fairley, will be presenting the attached slides and this presentation will also be made available on the Starpharma website at www.starpharma.com.

Download ASX Announcement: Starpharma Investor Presentation to Goldman Sachs Conference (PDF 3.7MB)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.